Page 3 of 3
123

Cappon GD, Bush B, Newgreen D, Finch GL, Alper RH. 2008. Tolterodine does not affect memory assessed by passive-avoidance response test in mice. Europ J Pharmacol 579:225–228, DOI: , online article.

View Abstract

Thompson CM, Subramaniam RP, Grafström RC. 2008. Mechanistic and dose considerations for supporting adverse pulmonary physiology in response to formaldehyde. Toxicol Appl Pharmacol 233(3):355–359.

View Abstract

Thompson CM, Sonawane B, Barton HA, DeWoskin RS, Schlosser P, Lipscomb JC, Chiu W, Krishnan K. 2008. Approaches for applications of physiologically based pharmacokinetic models in risk assessment. J Toxicol Environ Health, Part B 11(7):519–547.

View Abstract

Williams CW, Perry CS. 2008. Risk assessment for arsenic on indoor surfaces. Presented at the Society for Risk Analysis annual meeting, December 7-10, Boston, MA.

DeSesso JM, Watson RE, Keen CL, Hazelden KP, Haws LC, Li AA. 2008. Analysis and integration of developmental neurotoxicity and ancillary data into risk assessment: A case study of dimethoate. J Toxicol Environ Health A 72(2):94-109.

View Abstract

Hinerman J, Mueser T. Protein-protein interactions between bacteriophage T4 helicase assembly protein and single-stranded DNA binding protein. Poster presented to Ohio Crystallographic Symposium Meeting, University of Toledo, Toledo, OH, fall 2007.

Page 3 of 3
123